These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 10643834)

  • 1. Obesity, weight change, fasting insulin, proinsulin, C-peptide, and insulin-like growth factor-1 levels in women with and without breast cancer: the Rancho Bernardo Study.
    Jernström H; Barrett-Connor E
    J Womens Health Gend Based Med; 1999 Dec; 8(10):1265-72. PubMed ID: 10643834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women.
    Gunter MJ; Hoover DR; Yu H; Wassertheil-Smoller S; Rohan TE; Manson JE; Li J; Ho GY; Xue X; Anderson GL; Kaplan RC; Harris TG; Howard BV; Wylie-Rosett J; Burk RD; Strickler HD
    J Natl Cancer Inst; 2009 Jan; 101(1):48-60. PubMed ID: 19116382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating IGF binding protein-1 is inversely associated with leptin in non-obese men and obese postmenopausal women.
    Söderberg S; Ahrén B; Eliasson M; Dinesen B; Brismar K; Olsson T
    Eur J Endocrinol; 2001 Mar; 144(3):283-90. PubMed ID: 11248749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fasting glucose is a risk factor for breast cancer: a prospective study.
    Muti P; Quattrin T; Grant BJ; Krogh V; Micheli A; Schünemann HJ; Ram M; Freudenheim JL; Sieri S; Trevisan M; Berrino F
    Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1361-8. PubMed ID: 12433712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective study of plasma C-peptide and colorectal cancer risk in men.
    Ma J; Giovannucci E; Pollak M; Leavitt A; Tao Y; Gaziano JM; Stampfer MJ
    J Natl Cancer Inst; 2004 Apr; 96(7):546-53. PubMed ID: 15069117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex differences in the association between proinsulin and intact insulin with coronary heart disease in nondiabetic older adults: the Rancho Bernardo Study.
    Oh JY; Barrett-Connor E; Wedick NM
    Circulation; 2002 Mar; 105(11):1311-6. PubMed ID: 11901041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating levels of insulin-like growth factor I, its binding proteins -1,-2, -3, C-peptide and risk of postmenopausal breast cancer.
    Keinan-Boker L; Bueno De Mesquita HB; Kaaks R; Van Gils CH; Van Noord PA; Rinaldi S; Riboli E; Seidell JC; Grobbee DE; Peeters PH
    Int J Cancer; 2003 Aug; 106(1):90-5. PubMed ID: 12794762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating insulin and c-peptide levels and risk of breast cancer among predominately premenopausal women.
    Eliassen AH; Tworoger SS; Mantzoros CS; Pollak MN; Hankinson SE
    Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):161-4. PubMed ID: 17220346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized trial of tamoxifen versus combined tamoxifen and octreotide LAR Therapy in the adjuvant treatment of early-stage breast cancer in postmenopausal women: NCIC CTG MA.14.
    Pritchard KI; Shepherd LE; Chapman JA; Norris BD; Cantin J; Goss PE; Dent SF; Walde D; Vandenberg TA; Findlay B; O'Reilly SE; Wilson CF; Han L; Piura E; Whelan TJ; Pollak MN
    J Clin Oncol; 2011 Oct; 29(29):3869-76. PubMed ID: 21911723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II study of metformin for reduction of obesity-associated breast cancer risk: a randomized controlled trial protocol.
    Martinez JA; Chalasani P; Thomson CA; Roe D; Altbach M; Galons JP; Stopeck A; Thompson PA; Villa-Guillen DE; Chow HH
    BMC Cancer; 2016 Jul; 16():500. PubMed ID: 27430256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum concentrations of IGF-I, IGFBP-3 and c-peptide and risk of hyperplasia and cancer of the breast in postmenopausal women.
    Schairer C; Hill D; Sturgeon SR; Fears T; Pollak M; Mies C; Ziegler RG; Hoover RN; Sherman ME
    Int J Cancer; 2004 Feb; 108(5):773-9. PubMed ID: 14696106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of obesity and physical activity with C-peptide, leptin, and insulin-like growth factors in breast cancer survivors.
    Irwin ML; McTiernan A; Bernstein L; Gilliland FD; Baumgartner R; Baumgartner K; Ballard-Barbash R
    Cancer Epidemiol Biomarkers Prev; 2005 Dec; 14(12):2881-8. PubMed ID: 16365005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women.
    Kaaks R; Toniolo P; Akhmedkhanov A; Lukanova A; Biessy C; Dechaud H; Rinaldi S; Zeleniuch-Jacquotte A; Shore RE; Riboli E
    J Natl Cancer Inst; 2000 Oct; 92(19):1592-600. PubMed ID: 11018095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective study of C-peptide, insulin-like growth factor-I, insulin-like growth factor binding protein-1, and the risk of colorectal cancer in women.
    Wei EK; Ma J; Pollak MN; Rifai N; Fuchs CS; Hankinson SE; Giovannucci E
    Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):850-5. PubMed ID: 15824155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between carbohydrate metabolism and serum insulin-like growth factor system in postmenopausal women: comparison of endometrial cancer patients with healthy controls.
    Rutanen EM; Stenman S; Blum W; Kärkkäinen T; Lehtovirta P; Stenman UH
    J Clin Endocrinol Metab; 1993 Jul; 77(1):199-204. PubMed ID: 7686914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating levels of insulin-like growth factors, their binding proteins, and breast cancer risk.
    Schernhammer ES; Holly JM; Pollak MN; Hankinson SE
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):699-704. PubMed ID: 15767352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obesity, body size, and risk of postmenopausal breast cancer: the Women's Health Initiative (United States).
    Morimoto LM; White E; Chen Z; Chlebowski RT; Hays J; Kuller L; Lopez AM; Manson J; Margolis KL; Muti PC; Stefanick ML; McTiernan A
    Cancer Causes Control; 2002 Oct; 13(8):741-51. PubMed ID: 12420953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with circulating levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in 740 women at risk for breast cancer.
    Johansson H; Baglietto L; Guerrieri-Gonzaga A; Bonanni B; Mariette F; Macis D; Serrano D; Sandri MT; Decensi A
    Breast Cancer Res Treat; 2004 Nov; 88(1):63-73. PubMed ID: 15538047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of serum proinsulin with hormone replacement therapy in nondiabetic older women: the Rancho Bernardo Study.
    Kim DJ; Barrett-Connor E
    Diabetes Care; 2006 Mar; 29(3):618-24. PubMed ID: 16505516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer.
    Krajcik RA; Borofsky ND; Massardo S; Orentreich N
    Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1566-73. PubMed ID: 12496045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.